OpenVSafe by OpenVAERS
Search V-safe

YD5-28565-61664

5 vaccinations 18 coded responses 47 check-ins 18 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
787 / TX
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Registered in v-safe
  2. 2021-01-08
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-08
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  8. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-29
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Nausea · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Armpit pain on the injected arm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary mass, Axillary pain — Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tiredness
    Free text: Very painful lump in armpit of the arm of the injection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Oedema peripheral — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Fatigue or tiredness
    Free text: Lump in armpit, pain radiating to upper chest, probably lymph node involvement
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Lymph node pain, Lymphadenopathy, Oedema peripheral — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body aches
    Free text: Swollen, painful armpit and lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tiredness
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body aches
    Free text: Minor swelling in lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-02-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-26
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-03-05
    Survey response — day 35, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Be unable to work
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-03-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-30
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-30
    Survey response — 6 months, dose 2
    MedDRA: Haematocrit decreased, Haemoglobin decreased, Tinnitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Tinnitus, low hematocrit/hemoglobin levels
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-07-30
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-08-13
  30. 2021-09-03
    Dose 3 — Pfizer-BioNTech
  31. 2021-09-29
    Survey response — day 21, dose 3
    MedDRA: Depression — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Depression
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-09-29
    Report sent to call center — day 21, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2021-10-01
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  34. 2021-10-01
  35. 2021-10-08
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  36. 2021-10-15
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-03
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  38. 2022-03-06
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  39. 2022-05-20
    Dose 4 — Pfizer-BioNTech
  40. 2022-05-22
    Survey response — days 1–6 daily, dose 4
    MedDRA: Visual impairment — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain
    Free text: Vision difficulty
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-05-24
    Survey response — days 1–6 daily, dose 4
    MedDRA: Office visit, Visual impairment — Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tiredness · Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Vision distortion · Healthcare visit (other): In person office visit
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-05-24
    Report sent to call center — days 1–6 daily, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  43. 2022-05-25
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  44. 2022-05-25
  45. 2022-05-25
  46. 2022-05-25
  47. 2022-05-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches
    Adult check-in
  48. 2022-05-27
    Health check-in — day 7, dose 4
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  49. 2022-06-03
    Survey response — day 14, dose 4
    MedDRA: Arthralgia, Back pain — Feeling: Fair
    Free text: Increased back and joint pain
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-06-10
    Survey response — day 21, dose 4
    MedDRA: Palpitations — Feeling: Fair
    Free text: Heart palpitations
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-06-17
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-06-24
    Survey response — day 35, dose 4
    MedDRA: Tinnitus, Visual impairment — Feeling: Fair
    Free text: Increase in tinnitus. Increased vision difficulties.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-07-01
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  54. 2022-08-19
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-09-17
    Dose 5 — Moderna
  56. 2022-10-09
    Survey response — day 21, dose 5
    MedDRA: Arthralgia, Dizziness, Eczema, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches, dizziness, joint pain, eczema, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-10-15
    Survey response — day 28, dose 5
    MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  58. 2022-10-22
    Survey response — day 35, dose 5
    MedDRA: Hypertension — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Hypertension
    MedDRA releases: 2024-11 · check-in free text available
  59. 2022-10-22
    Report sent to call center — day 35, dose 5
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  60. 2022-10-25
  61. 2022-10-25
  62. 2022-10-25
  63. 2022-10-25
  64. 2022-10-29
    Survey response — day 42, dose 5
    MedDRA: Dizziness, Insomnia — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Dizziness, insomnia
    MedDRA releases: 2024-11 · check-in free text available
  65. 2022-12-17
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in
  66. 2023-03-18
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Pfizer-BioNTech
22021-01-29Pfizer-BioNTech
32021-09-03Pfizer-BioNTech No
42022-05-20Pfizer-BioNTech No
52022-09-17Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-07-30 Unsuccessful
2021-09-29 Unsuccessful
2022-05-24 Unsuccessful
2022-10-22 Unsuccessful

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-30

Systemic reaction (other): Armpit pain on the injected arm

2021-01-31

Systemic reaction (other): Very painful lump in armpit of the arm of the injection.

2021-02-01

Systemic reaction (other): Lump in armpit, pain radiating to upper chest, probably lymph node involvement

2021-02-02

Systemic reaction (other): Swollen, painful armpit and lymph nodes

2021-02-03

Systemic reaction (other): Swollen lymph nodes

2021-02-04

Systemic reaction (other): Minor swelling in lymph nodes

Release 5 — day 35, dose 2

2021-03-05

Symptoms: Swollen lymph nodes

Release 9 — 6 months, dose 2

2021-07-30

Symptoms: Tinnitus, low hematocrit/hemoglobin levels

Release 9 — day 21, dose 3

2021-09-29

Symptoms: Depression

Release 11 — days 1–6 daily, dose 4

2022-05-22

Systemic reaction (other): Vision difficulty

2022-05-24

Systemic reaction (other): Vision distortion
Healthcare visit (other): In person office visit

Release 11 — day 14, dose 4

2022-06-03

Symptoms: Increased back and joint pain

Release 12 — day 21, dose 4

2022-06-10

Symptoms: Heart palpitations

Release 12 — day 35, dose 4

2022-06-24

Symptoms: Increase in tinnitus. Increased vision difficulties.

Release 12 — day 21, dose 5

2022-10-09

Symptoms: Headaches, dizziness, joint pain, eczema, fatigue

Release 12 — day 28, dose 5

2022-10-15

Symptoms: Fatigue

Release 12 — day 35, dose 5

2022-10-22

Symptoms: Hypertension

Release 12 — day 42, dose 5

2022-10-29

Symptoms: Dizziness, insomnia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDArthralgia · · ✓
SDBack pain · · ✓
SDDepression · · ✓
SDDizziness · · ✓
SDEczema · · ✓
SDFatigue · · ✓
SDHaematocrit decreased ✓ · ✓
SDHaemoglobin decreased ✓ · ✓
SDHeadache · · ✓
SDHypertension · · ✓
SDInsomnia · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDPalpitations · · ✓
SDTinnitus ✓ · ✓
SDVisual impairment · · ✓
SROAxillary mass ✓ ✓ ✓
SROAxillary pain ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROOedema peripheral ✓ ✓ ✓
SROVisual impairment · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release